Active Ingredient: EXENATIDE SYNTHETIC
Proprietary Name: BYDUREON BCISE
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; SUBCUTANEOUS
Strength: 2MG/0.85ML (2MG/0.85ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209210
Product Number: 001
Approval Date: Oct 20, 2017
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Prescription
Patent and Exclusivity Information
